Nature Foods for the Treatment of Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Sun, Mengxia [1 ]
Ye, Hua [1 ,2 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo, Peoples R China
[2] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315040, Peoples R China
关键词
mechanism; NAFLD; nature food; therapy; DIET-INDUCED OBESITY; LYCIUM-BARBARUM; HEPATIC STEATOSIS; CHLOROGENIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; LIPID PROFILE; DOUBLE-BLIND; HEPG2; CELLS; PPAR-GAMMA;
D O I
10.1089/jmf.2022.K.0052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The etiology of NAFLD is highly heterogeneous, which occurs and develops under the joint action of metabolism, inflammation, genetics, environment, and gut microbiota. At present, the principal therapeutic modalities targeting NAFLD are lifestyle interventions such as weight loss through diet and exercise. At present, there is no established therapy for the treatment of NAFLD, and many therapies are associated with a variety of side effects. A great number of in vitro and in vivo experiments have indicated that there are many natural foods that have therapeutic potential for NAFLD. This review summarizes the natural foods and their mechanisms that were found in recent years, furthermore, provides further information relevant to the treatment of NAFLD.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] Nonalcoholic fatty liver disease: From lipid profile to treatment
    Miura K.
    Ohnishi H.
    Clinical Journal of Gastroenterology, 2012, 5 (5) : 313 - 321
  • [22] Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
    Khoo, Stanley
    Wong, Vincent Wai-Sun
    Goh, George Boon-Bee
    Fan, Jiangao
    Chan, Wah Kheong
    Seto, Wai-Kay
    Chow, Wan Cheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (02) : 320 - 325
  • [23] Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
    Chen, Ze
    Yu, Yao
    Cai, Jingjing
    Li, Hongliang
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (12) : 903 - 914
  • [24] Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
    Ma, Junli
    Zhou, Qihang
    Li, Houkai
    NUTRIENTS, 2017, 9 (10)
  • [25] Methionine cycle in nonalcoholic fatty liver disease and its potential applications
    Wang, Haoyu
    Wu, Yanwei
    Tang, Wei
    BIOCHEMICAL PHARMACOLOGY, 2022, 200
  • [26] Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
    Kim, Kyung-Soo
    Lee, Byung-Wan
    Kim, Yong Jin
    Lee, Dae Ho
    Cha, Bong-Soo
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2019, 43 (02) : 127 - 143
  • [27] Catalase and nonalcoholic fatty liver disease
    Shin, Su-Kyung
    Cho, Hyun-Woo
    Song, Seung-Eun
    Song, Dae-Kyu
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2018, 470 (12): : 1721 - 1737
  • [28] Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults
    Malinowski, Scott S.
    Byrd, Jennifer S.
    Bell, Allison M.
    Wofford, Marion R.
    Riche, Daniel M.
    PHARMACOTHERAPY, 2013, 33 (02): : 223 - 242
  • [29] Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
    Arab, Juan Pablo
    Arrese, Marco
    Trauner, Michael
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13, 2018, 13 : 321 - 350
  • [30] Pharmacotherapy for Nonalcoholic Fatty Liver Disease
    Gawrieh, Samer
    Chalasani, Naga
    SEMINARS IN LIVER DISEASE, 2015, 35 (03) : 338 - 348